Selected article for: "intra alveolar pressure and Spontaneous pneumomediastinum"

Author: Jatoi, Tahir Ahmed; Khan, Anosh Aslam; Mohiuddin, Osama; Choudhry, Muhammad Saad; Yasmin, Farah; Jalees, Sumeen
Title: Spontaneous pneumomediastinum and subcutaneous emphysema in a non-intubated COVID-19 patient: a case report
  • Cord-id: fkmek75h
  • Document date: 2021_1_14
  • ID: fkmek75h
    Snippet: The development of spontaneous pneumomediastinum and subcutaneous emphysema are few of the rare clinical manifestations observed in coronavirus disease-19 (COVID-19) patients which are yet to be fully understood. Most cases of spontaneous pneumomediastinum arise due to factors causing high intra-alveolar pressure. Herein, we report a case of a COVID-19 positive elderly male, who presented with spontaneous pneumomediastinum and subcutaneous emphysema unrelated to high-pressure ventilatory measure
    Document: The development of spontaneous pneumomediastinum and subcutaneous emphysema are few of the rare clinical manifestations observed in coronavirus disease-19 (COVID-19) patients which are yet to be fully understood. Most cases of spontaneous pneumomediastinum arise due to factors causing high intra-alveolar pressure. Herein, we report a case of a COVID-19 positive elderly male, who presented with spontaneous pneumomediastinum and subcutaneous emphysema unrelated to high-pressure ventilatory measures, detected on chest computed tomography (CT). Despite acute medical care, the patient progressed towards a more serious clinical course. Male gender and diffuse alveolar damage caused by COVID-19 seems to be the most relevant association in this case. However, we have enlightened other possible pathological mechanisms and their association with severity index of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and low grade fever: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and lung compliance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung damage severity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and lung elastic: 1, 2, 3
    • acute respiratory syndrome and lung field: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory syndrome and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung pathology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung region: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and lung volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and macklin effect: 1, 2, 3
    • lopinavir ritonavir and low grade fever: 1, 2
    • lopinavir ritonavir and lung compliance: 1
    • lopinavir ritonavir and lung damage: 1, 2, 3, 4, 5, 6
    • lopinavir ritonavir and lung field: 1
    • lopinavir ritonavir and lung infection: 1, 2, 3, 4, 5, 6, 7, 8
    • lopinavir ritonavir and lung pathology: 1
    • low grade fever and lung damage: 1
    • low grade fever and lung infection: 1, 2